CPHI Financial Facts
Selling expenses: 927.19KNet other income: -1.73M
See Full Income Statement
Accrued expenses: 91.7K
Additional paid-in capital: 23.59M
See Full Balance Sheet
China Pharma Holdings (CPHI) Earnings
|
Expand Research on CPHI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/25  |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/18/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/31/23 | Q422 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/18/22 | Q322 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/29/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/18/22 | Q222 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/20 |  |
Q220 | $0.00 | N/A | N/A | $3.77M | $2.57M | N/A |  | | Details |
